nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA5B—Hydrochlorothiazide—nephrolithiasis	0.167	0.191	CbGbCtD
Methazolamide—CA9—Hydrochlorothiazide—nephrolithiasis	0.144	0.164	CbGbCtD
Methazolamide—CA12—Hydrochlorothiazide—nephrolithiasis	0.144	0.164	CbGbCtD
Methazolamide—CA1—Hydrochlorothiazide—nephrolithiasis	0.134	0.153	CbGbCtD
Methazolamide—CA4—Hydrochlorothiazide—nephrolithiasis	0.126	0.144	CbGbCtD
Methazolamide—CA2—Hydrochlorothiazide—nephrolithiasis	0.116	0.133	CbGbCtD
Methazolamide—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.0446	0.051	CbGbCtD
Methazolamide—Acetazolamide—AQP1—nephrolithiasis	0.00893	1	CrCbGaD
Methazolamide—CA2—collecting duct of renal tubule—nephrolithiasis	0.00731	0.192	CbGeAlD
Methazolamide—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.00687	0.157	CbGpPWpGaD
Methazolamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00586	0.134	CbGpPWpGaD
Methazolamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00562	0.129	CbGpPWpGaD
Methazolamide—CA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00539	0.123	CbGpPWpGaD
Methazolamide—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.00423	0.125	CcSEcCtD
Methazolamide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0032	0.0731	CbGpPWpGaD
Methazolamide—CYP2C19—urine—nephrolithiasis	0.00285	0.0748	CbGeAlD
Methazolamide—CYP2C9—urine—nephrolithiasis	0.00221	0.058	CbGeAlD
Methazolamide—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00218	0.0643	CcSEcCtD
Methazolamide—CYP2E1—urine—nephrolithiasis	0.00209	0.0549	CbGeAlD
Methazolamide—CA7—renal system—nephrolithiasis	0.00191	0.0503	CbGeAlD
Methazolamide—CA7—kidney—nephrolithiasis	0.00185	0.0486	CbGeAlD
Methazolamide—CYP3A4—urine—nephrolithiasis	0.00168	0.0442	CbGeAlD
Methazolamide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00166	0.0489	CcSEcCtD
Methazolamide—CYP2D6—urine—nephrolithiasis	0.00166	0.0435	CbGeAlD
Methazolamide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0471	CcSEcCtD
Methazolamide—SLC22A6—nephron tubule—nephrolithiasis	0.00153	0.0401	CbGeAlD
Methazolamide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00146	0.0431	CcSEcCtD
Methazolamide—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00146	0.0431	CcSEcCtD
Methazolamide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00142	0.0419	CcSEcCtD
Methazolamide—SLC22A6—cortex of kidney—nephrolithiasis	0.00131	0.0343	CbGeAlD
Methazolamide—CA12—renal system—nephrolithiasis	0.00124	0.0327	CbGeAlD
Methazolamide—CA12—kidney—nephrolithiasis	0.0012	0.0316	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0341	CcSEcCtD
Methazolamide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00101	0.0298	CcSEcCtD
Methazolamide—CA1—renal system—nephrolithiasis	0.000985	0.0259	CbGeAlD
Methazolamide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00098	0.0289	CcSEcCtD
Methazolamide—CA1—kidney—nephrolithiasis	0.000953	0.025	CbGeAlD
Methazolamide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000942	0.0278	CcSEcCtD
Methazolamide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000922	0.0272	CcSEcCtD
Methazolamide—CA4—nephron tubule—nephrolithiasis	0.000847	0.0222	CbGeAlD
Methazolamide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000839	0.0247	CcSEcCtD
Methazolamide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000827	0.0244	CcSEcCtD
Methazolamide—CA4—renal system—nephrolithiasis	0.00077	0.0202	CbGeAlD
Methazolamide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000756	0.0223	CcSEcCtD
Methazolamide—CA4—kidney—nephrolithiasis	0.000745	0.0195	CbGeAlD
Methazolamide—CA4—cortex of kidney—nephrolithiasis	0.000725	0.019	CbGeAlD
Methazolamide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000717	0.0211	CcSEcCtD
Methazolamide—CA2—nephron tubule—nephrolithiasis	0.000703	0.0184	CbGeAlD
Methazolamide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000696	0.0205	CcSEcCtD
Methazolamide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000694	0.0205	CcSEcCtD
Methazolamide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000691	0.0204	CcSEcCtD
Methazolamide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00065	0.0192	CcSEcCtD
Methazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00064	0.0146	CbGpPWpGaD
Methazolamide—CA2—renal system—nephrolithiasis	0.000639	0.0168	CbGeAlD
Methazolamide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000636	0.0187	CcSEcCtD
Methazolamide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00063	0.0186	CcSEcCtD
Methazolamide—CA2—kidney—nephrolithiasis	0.000617	0.0162	CbGeAlD
Methazolamide—CA2—cortex of kidney—nephrolithiasis	0.000601	0.0158	CbGeAlD
Methazolamide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000601	0.0177	CcSEcCtD
Methazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000595	0.0136	CbGpPWpGaD
Methazolamide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000566	0.0167	CcSEcCtD
Methazolamide—CYP2E1—nephron tubule—nephrolithiasis	0.000563	0.0148	CbGeAlD
Methazolamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00056	0.0165	CcSEcCtD
Methazolamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000555	0.0164	CcSEcCtD
Methazolamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000548	0.0162	CcSEcCtD
Methazolamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000543	0.016	CcSEcCtD
Methazolamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000519	0.0153	CcSEcCtD
Methazolamide—CYP2E1—renal system—nephrolithiasis	0.000512	0.0134	CbGeAlD
Methazolamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000501	0.0148	CcSEcCtD
Methazolamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000498	0.0147	CcSEcCtD
Methazolamide—CYP2E1—kidney—nephrolithiasis	0.000495	0.013	CbGeAlD
Methazolamide—CYP2E1—cortex of kidney—nephrolithiasis	0.000482	0.0127	CbGeAlD
Methazolamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000452	0.0133	CcSEcCtD
Methazolamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000431	0.0127	CcSEcCtD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00042	0.0096	CbGpPWpGaD
Methazolamide—CYP3A4—renal system—nephrolithiasis	0.000412	0.0108	CbGeAlD
Methazolamide—CYP2D6—renal system—nephrolithiasis	0.000405	0.0106	CbGeAlD
Methazolamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000401	0.0118	CcSEcCtD
Methazolamide—CYP3A4—kidney—nephrolithiasis	0.000398	0.0105	CbGeAlD
Methazolamide—Rash—Hydrochlorothiazide—nephrolithiasis	0.000397	0.0117	CcSEcCtD
Methazolamide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000397	0.0117	CcSEcCtD
Methazolamide—Headache—Hydrochlorothiazide—nephrolithiasis	0.000395	0.0116	CcSEcCtD
Methazolamide—CYP2D6—kidney—nephrolithiasis	0.000392	0.0103	CbGeAlD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000384	0.00878	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000384	0.00878	CbGpPWpGaD
Methazolamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000374	0.011	CcSEcCtD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000291	0.00665	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000291	0.00665	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000271	0.00619	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000271	0.00619	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GRHPR—nephrolithiasis	0.000261	0.00596	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GRHPR—nephrolithiasis	0.000254	0.00581	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GRHPR—nephrolithiasis	0.000254	0.00581	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000241	0.00551	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000239	0.00547	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000239	0.00547	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GRHPR—nephrolithiasis	0.000237	0.00542	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GRHPR—nephrolithiasis	0.000237	0.00542	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AGXT—nephrolithiasis	0.000232	0.00531	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000228	0.00521	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AGXT—nephrolithiasis	0.000226	0.00518	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AGXT—nephrolithiasis	0.000226	0.00518	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GRHPR—nephrolithiasis	0.00022	0.00502	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000213	0.00488	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AGXT—nephrolithiasis	0.000211	0.00483	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AGXT—nephrolithiasis	0.000211	0.00483	CbGpPWpGaD
Methazolamide—CA14—Metabolism—SLC26A1—nephrolithiasis	0.000198	0.00452	CbGpPWpGaD
Methazolamide—CA14—Metabolism—APRT—nephrolithiasis	0.000198	0.00452	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AGXT—nephrolithiasis	0.000196	0.00448	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000195	0.00446	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000195	0.00446	CbGpPWpGaD
Methazolamide—CA6—Metabolism—SLC26A1—nephrolithiasis	0.000193	0.0044	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—SLC26A1—nephrolithiasis	0.000193	0.0044	CbGpPWpGaD
Methazolamide—CA6—Metabolism—APRT—nephrolithiasis	0.000193	0.0044	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—APRT—nephrolithiasis	0.000193	0.0044	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—SLC26A1—nephrolithiasis	0.00018	0.00411	CbGpPWpGaD
Methazolamide—CA7—Metabolism—SLC26A1—nephrolithiasis	0.00018	0.00411	CbGpPWpGaD
Methazolamide—CA7—Metabolism—APRT—nephrolithiasis	0.00018	0.00411	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—APRT—nephrolithiasis	0.00018	0.00411	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000176	0.00402	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GRHPR—nephrolithiasis	0.000175	0.00401	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GRHPR—nephrolithiasis	0.000168	0.00384	CbGpPWpGaD
Methazolamide—CA12—Metabolism—APRT—nephrolithiasis	0.000167	0.00381	CbGpPWpGaD
Methazolamide—CA12—Metabolism—SLC26A1—nephrolithiasis	0.000167	0.00381	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000162	0.00369	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GRHPR—nephrolithiasis	0.000161	0.00368	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00016	0.00366	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AGXT—nephrolithiasis	0.000156	0.00357	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AGXT—nephrolithiasis	0.00015	0.00342	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000148	0.00338	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000148	0.00338	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AGXT—nephrolithiasis	0.000144	0.00328	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GRHPR—nephrolithiasis	0.000142	0.00324	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AQP1—nephrolithiasis	0.000141	0.00322	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000137	0.00314	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000137	0.00314	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AQP1—nephrolithiasis	0.000137	0.00314	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AQP1—nephrolithiasis	0.000137	0.00314	CbGpPWpGaD
Methazolamide—CA4—Metabolism—APRT—nephrolithiasis	0.000133	0.00304	CbGpPWpGaD
Methazolamide—CA4—Metabolism—SLC26A1—nephrolithiasis	0.000133	0.00304	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AQP1—nephrolithiasis	0.000128	0.00293	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AQP1—nephrolithiasis	0.000128	0.00293	CbGpPWpGaD
Methazolamide—CA2—Metabolism—SLC26A1—nephrolithiasis	0.000127	0.00291	CbGpPWpGaD
Methazolamide—CA2—Metabolism—APRT—nephrolithiasis	0.000127	0.00291	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CHRM3—nephrolithiasis	0.000127	0.00291	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AGXT—nephrolithiasis	0.000126	0.00289	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CHRM3—nephrolithiasis	0.000124	0.00284	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CHRM3—nephrolithiasis	0.000124	0.00284	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000123	0.0028	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000123	0.0028	CbGpPWpGaD
Methazolamide—CA1—Metabolism—SLC26A1—nephrolithiasis	0.000122	0.00279	CbGpPWpGaD
Methazolamide—CA1—Metabolism—APRT—nephrolithiasis	0.000122	0.00279	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AQP1—nephrolithiasis	0.000119	0.00271	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CHRM3—nephrolithiasis	0.000116	0.00265	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CHRM3—nephrolithiasis	0.000116	0.00265	CbGpPWpGaD
Methazolamide—CA9—Metabolism—SLC26A1—nephrolithiasis	0.000107	0.00245	CbGpPWpGaD
Methazolamide—CA9—Metabolism—APRT—nephrolithiasis	0.000107	0.00245	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CHRM3—nephrolithiasis	0.000107	0.00245	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000106	0.00242	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	9.8e-05	0.00224	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AQP1—nephrolithiasis	9.46e-05	0.00216	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AQP1—nephrolithiasis	9.07e-05	0.00207	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AQP1—nephrolithiasis	8.7e-05	0.00199	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CHRM3—nephrolithiasis	8.56e-05	0.00196	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CHRM3—nephrolithiasis	8.21e-05	0.00188	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CHRM3—nephrolithiasis	7.87e-05	0.0018	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AQP1—nephrolithiasis	7.65e-05	0.00175	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CHRM3—nephrolithiasis	6.92e-05	0.00158	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GRHPR—nephrolithiasis	5.14e-05	0.00117	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AGXT—nephrolithiasis	4.58e-05	0.00105	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GRHPR—nephrolithiasis	3.96e-05	0.000906	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APRT—nephrolithiasis	3.89e-05	0.00089	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	3.89e-05	0.00089	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GRHPR—nephrolithiasis	3.65e-05	0.000834	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GRHPR—nephrolithiasis	3.61e-05	0.000827	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AGXT—nephrolithiasis	3.53e-05	0.000808	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AGXT—nephrolithiasis	3.25e-05	0.000743	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AGXT—nephrolithiasis	3.22e-05	0.000737	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	3e-05	0.000687	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APRT—nephrolithiasis	3e-05	0.000687	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AQP1—nephrolithiasis	2.77e-05	0.000634	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	2.76e-05	0.000632	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APRT—nephrolithiasis	2.76e-05	0.000632	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APRT—nephrolithiasis	2.74e-05	0.000626	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	2.74e-05	0.000626	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CHRM3—nephrolithiasis	2.51e-05	0.000574	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.38e-05	0.000545	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AQP1—nephrolithiasis	2.14e-05	0.000489	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.12e-05	0.000486	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AQP1—nephrolithiasis	1.97e-05	0.00045	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AQP1—nephrolithiasis	1.95e-05	0.000446	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CHRM3—nephrolithiasis	1.94e-05	0.000443	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.81e-05	0.000413	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APRT—nephrolithiasis	1.81e-05	0.000413	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.78e-05	0.000407	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CHRM3—nephrolithiasis	1.77e-05	0.000404	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.29e-05	0.000294	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.16e-05	0.000266	CbGpPWpGaD
